EPISODE · Apr 15, 2026 · 8 MIN
Dr Andrew Kiselica - Why "Normal" Cognition Is Hindering Preclinical Alzheimer’s Trials
from Dementia Researcher Blogs
Dr Andrew M. Kiselica, narrating a new blog he wrote for the Dementia Researcher website.Why are preclinical Alzheimer’s trials struggling to show results? Andrew and colleagues argue the issue may not just be biology or timing, but how we define “normal.” By grouping cognitively unimpaired individuals together, trials overlook meaningful differences in subtle symptoms. This blog explores how recognising objective subtle cognitive decline, supported by digital tools and refined measures, could improve participant selection and increase the chances of detecting real treatment effects.Find the original text, and narration here on our website.https://www.dementiaresearcher.nihr.ac.uk/blog-why-normal-cognition-is-hindering-preclinical-alzheimers-trials/--Dr Andrew M. Kiselica is an Associate Professor at the University of Georgia whose work focuses on early detection of cognitive decline in Alzheimer’s disease. He contributes to the Working Group on Objective Subtle Cognitive Decline in Alzheimer’s Disease.Leave us a Tiphttps://dementia-researcher.captivate.fm/supportFollow us on social media:https://www.instagram.com/dementia_researcher/ https://www.facebook.com/Dementia.Researcher/https://www.twitter.com/demrescommunityhttps://www.linkedin.com/company/dementia-researcher https://bsky.app/profile/dementiaresearcher.bsky.socialDownload and Register with our Community App:https://www.onelink.to/dementiaresearcher
NOW PLAYING
Dr Andrew Kiselica - Why "Normal" Cognition Is Hindering Preclinical Alzheimer’s Trials
No transcript for this episode yet
Similar Episodes
Jun 19, 2026 ·29m
Jun 16, 2026 ·14m
Jun 12, 2026 ·27m
Jun 11, 2026 ·43m
Jun 9, 2026 ·14m
Jun 5, 2026 ·29m